EXTENDED BENCH

What this means for you

Not registered yet, but its 06 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99322680

Mark type

Stylized text

Filed

06 Aug 2025

Attorney of record

Laura A. Kees

Goods and services

• Class 001 — Chemicals: Chemicals for use in the pharmaceutical industry, namely, for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, rare ear, nose, and throat diseases, animal health disorders, cardiovascular diseases and disorders, central nervous system disorders, dermatologic disorders, endocrine system disorders, gastrointestinal diseases, genito urinary system and sex hormone imbalances, male health disorders, women's health disorders, mental health disorders, musculoskeletal disorders, renal disorders, cancer, ophthalmic disorders, renal diseases, respiratory diseases, trauma and injury; active chemical ingredients for use in the manufacture of pharmaceuticals.
• Class 005 — Pharmaceuticals: Pharmaceuticals, namely, psychotropics, antihelmintics, anti-infectives, lipid lowering agents, inducers of erections, induction agents, neuromuscular blocking agents, sedatives, anti-cancer medication, anti-inflammatories, anti-fungals, anti-bacterials, anti-spasmodics, appetite stimulants, bronchodilators, appetite suppressants, anti-convulsives, neuroprotective drugs, anti-anxiety medication, anti-depressants, anti-ischemics, anti-psychotics; pharmaceutical preparations for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, and rare ear, nose, and throat diseases; pharmaceuticals for medical or veterinary purposes, namely, pharmaceutical preparations and substances for the treatment of viral, infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; medicine for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, and rare ear, nose, and throat diseases.
• Class 040 — Treatment of materials: Custom manufacturing in the field of pharmaceuticals; processing of pharmaceuticals; custom manufacture of pharmaceuticals; treatment of pharmaceuticals; treatment and disposal being destruction of pharmaceutical waste; information, advice and consultancy services in relation to the aforesaid services.
• Class 042 — Scientific and technological services: Pharmaceutical research services; pharmaceutical development services; pharmaceutical design services; testing of pharmaceuticals; conducting clinical trials for others relating to pharmaceuticals and chemicals; pharmaceutical analysis, namely, chemical composition analysis, testing, analysis, and evaluation of pharmaceuticals to determine conformity with certification standards; pharmaceutical laboratory research services relating to pharmaceuticals; pharmaceutical product evaluation; pharmaceutical reports, namely, preparation of reports relating to pharmaceutical research; inspection of pharmaceuticals; biological research services; quality control and authentication services for others in the field of pharmaceuticals; information, advice and consultancy services in relation to the aforesaid services

Owner

• Sterling Pharma Solutions Limited, Northumberland, GB

Prosecution history

• 23 Mar 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 23 Mar 2026 — FINAL REFUSAL E-MAILED
• 23 Mar 2026 — FINAL REFUSAL WRITTEN
• 17 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 17 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 17 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 19 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 19 Dec 2025 — NON-FINAL ACTION E-MAILED
• 19 Dec 2025 — NON-FINAL ACTION WRITTEN
• 19 Dec 2025 — ASSIGNED TO EXAMINER
• 06 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 06 Aug 2025 — APPLICATION FILING RECEIPT MAILED
• 06 Aug 2025 — NEW APPLICATION ENTERED